ArticleInternational journal of epidemiology and public health research2025
Investigation of the Impact of Social Vulnerability and Racial Disparity on COVID-19 Infection and Death Rates Among Georgians (USA).
Article in International journal of epidemiology and public health research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Introduction: The novel coronavirus (COVID-19) continues to shed light on the disproportionately negative impact of public health pandemics among racial/ethnic minorities and other systematically marginalized communities persistency experiencing poorer health and health outcomes. Far less statistical investigation has been conducted to confirm the disease agnostic social determinants correlated with the intersection of emergent crisis, chronic health conditions and local contexts to inform proactive response strategies. This study investigated the influence of Social Vulnerability (SV), barriers to access to vaccination and Racial Disparities (RD) on COVID-19 infection and death rates among Georgian residents using Georgia Department of Public Health data and County Health Rankings & Roadmaps. Method: We adjusted analyses for other predictors of outcomes by using the Poisson Generalized Linear Mixed Models (with county as the unit of analysis). We iteratively modeled county-specific infection/death rates as a function of the Social Vulnerability Index (SVI, % Racial Population Gap (RPG) [(60+years % White - %African Americans/Blacks (AA)/Black)], education, %unemployed, %uninsured, % obese, % fully vaccinated, racial differences in respiratory infection discharge rates and %AA /Black residents (w/o RPG in the model). Results: Per adjusted models' results of COVID-19 related death,, I) AA/Blacks, relative to Whites, were 51% more likely to die (p-value <0.0001), 1) by age-specific and overall estimates(p-values <0.0001 and 2) at a younger mean age (p-value < 0.0001), II) 1% increase in SVI increases the risk of death by 25% (p-value <0.0001) and III) risk of death decreases by 2.3% for every % increase in 60+ years old Whites vs. Black males county residents (p-value <0.0001). The case infection rate a) decreased by a.1) 0.1% for every percent population increase in the racial gap (i.e., more Whites than AA/Blacks in a county) (p-values = 0.0122) and a.2) 27% for every % increase of those fully vaccinated(p-value < 0.0001). The rates also increased by a) 17% with every 1% increase in SV Index p-value <0.0001) b) 1% for every 0.1% increase in those a) obese (p-value < 0.0001) and b) uninsured (p-value < 0.0001). Conclusions: Attention to the Social Vulnerability Index (SVI) factors associated with COVID-19 illness and death signal the need for proactive prevention and mitigation interventions prior to and in the wake of public health pandemics thereby bridging the health disparity gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.